Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial

Longevity of the novel ConvaTec infusion set with Lantern technology

(2021) Rayhan A. Lal et al.   DIABETES OBESITY & METABOLISM

The improved survival rate and cost-effectiveness of a 7-day continuous subcutaneous insulin infusion set

(2021) Timothy Kwa et al.   JOURNAL OF MEDICAL ECONOMICS

A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control

(2020) Delia Waldenmaier et al.   Diabetes Technology & Therapeutics

997-P: Testing a Novel Infusion Set for Extended Wear Duration

(2020) BRUCE A. BUCKINGHAM et al.   DIABETES

1012-P: Study of Insulin Stability Impact on Pump Therapy: Test Model Development

(2020) SARNATH CHATTARAJ et al.   DIABETES

986-P: Assessment of Adhesive Patches for an Extended-Wear Infusion Set

(2020) GINA ZHANG et al.   DIABETES

Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes

(2019) Maria O. Christensen et al.   Diabetes Technology & Therapeutics

Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study

(2018) Anna Korsgaard Berg et al.   Diabetes Technology & Therapeutics

Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey

(2018) Nadine Taleb et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies

(2016) Michael Gibney et al.   Diabetes Technology & Therapeutics

Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes

(2016) Andrew W. Karlin et al.   Diabetes Technology & Therapeutics

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

(2016) Richard M. Bergenstal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Randomized Trial of Infusion Set Function: Steel Versus Teflon

(2013) Parul J. Patel et al.   Diabetes Technology & Therapeutics

Nonmetabolic Complications of Continuous Subcutaneous Insulin Infusion: A Patient Survey

(2013) John C. Pickup et al.   Diabetes Technology & Therapeutics

Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion

(2009) Tina K. Thethi et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS